AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS ISOLATED FROM AIDS PATIENTS AFTER PROLONGED ADEFOVIR DIPIVOXIL THERAPY
Authors: MULATO AS LAMY PD MILLER MD LI WX ANTON KE HELLMANN NS CHERRINGTON JM
Citation: As. Mulato et al., GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS ISOLATED FROM AIDS PATIENTS AFTER PROLONGED ADEFOVIR DIPIVOXIL THERAPY, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1620-1628
A POINT MUTATION IN THE HUMAN CYTOMEGALOVIRUS DNA-POLYMERASE GENE SELECTED IN-VITRO BY CIDOFOVIR CONFERS A SLOW REPLICATION PHENOTYPE IN CELL-CULTURE
Authors: CIHLAR T FULLER MD MULATO AS CHERRINGTON JM
Citation: T. Cihlar et al., A POINT MUTATION IN THE HUMAN CYTOMEGALOVIRUS DNA-POLYMERASE GENE SELECTED IN-VITRO BY CIDOFOVIR CONFERS A SLOW REPLICATION PHENOTYPE IN CELL-CULTURE, Virology (New York, N.Y. Print), 248(2), 1998, pp. 382-393
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE EXPRESSING THE K70E MUTATION EXHIBITS A DECREASE IN SPECIFIC ACTIVITY AND PROCESSIVITY
Authors: MILLER MD LAMY PD FULLER MD MULATO AS MARGOT NA CIHLAR T CHERRINGTON JM
Citation: Md. Miller et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE EXPRESSING THE K70E MUTATION EXHIBITS A DECREASE IN SPECIFIC ACTIVITY AND PROCESSIVITY, Molecular pharmacology, 54(2), 1998, pp. 291-297
CHARACTERIZATION OF DRUG RESISTANCE-ASSOCIATED MUTATIONS IN THE HUMANCYTOMEGALOVIRUS DNA-POLYMERASE GENE BY USING RECOMBINANT MUTANT VIRUSES GENERATED FROM OVERLAPPING DNA FRAGMENTS
Authors: CIHLAR T FULLER MD CHERRINGTON JM
Citation: T. Cihlar et al., CHARACTERIZATION OF DRUG RESISTANCE-ASSOCIATED MUTATIONS IN THE HUMANCYTOMEGALOVIRUS DNA-POLYMERASE GENE BY USING RECOMBINANT MUTANT VIRUSES GENERATED FROM OVERLAPPING DNA FRAGMENTS, Journal of virology, 72(7), 1998, pp. 5927-5936
HIGH-LEVEL RESISTANCE OF CYTOMEGALOVIRUS TO GANCICLOVIR IS ASSOCIATEDWITH ALTERATIONS IN BOTH THE UL97 AND DNA-POLYMERASE GENES (VOL 176, PG 69, 1997)
Authors: SMITH IL CHERRINGTON JM JILES RE FULLER MD FREEMAN WR SPECTOR SA
Citation: Il. Smith et al., HIGH-LEVEL RESISTANCE OF CYTOMEGALOVIRUS TO GANCICLOVIR IS ASSOCIATEDWITH ALTERATIONS IN BOTH THE UL97 AND DNA-POLYMERASE GENES (VOL 176, PG 69, 1997), The Journal of infectious diseases, 177(4), 1998, pp. 1140-1141
EXPRESSION OF THE CATALYTIC SUBUNIT (UL54) AND THE ACCESSORY PROTEIN (UL44) OF HUMAN CYTOMEGALOVIRUS DNA-POLYMERASE IN A COUPLED IN-VITRO TRANSCRIPTION TRANSLATION SYSTEM/
Authors: CIHLAR T FULLER MD CHERRINGTON JM
Citation: T. Cihlar et al., EXPRESSION OF THE CATALYTIC SUBUNIT (UL54) AND THE ACCESSORY PROTEIN (UL44) OF HUMAN CYTOMEGALOVIRUS DNA-POLYMERASE IN A COUPLED IN-VITRO TRANSCRIPTION TRANSLATION SYSTEM/, Protein expression and purification, 11(2), 1997, pp. 209-218
ANTI-HIV ACTIVITY OF ADEFOVIR (PMEA) AND PMPA IN COMBINATION WITH ANTIRETROVIRAL COMPOUNDS - IN-VITRO ANALYSES
Authors: MULATO AS CHERRINGTON JM
Citation: As. Mulato et Jm. Cherrington, ANTI-HIV ACTIVITY OF ADEFOVIR (PMEA) AND PMPA IN COMBINATION WITH ANTIRETROVIRAL COMPOUNDS - IN-VITRO ANALYSES, Antiviral research, 36(2), 1997, pp. 91-97
IN-VITRO CHARACTERIZATION OF THE ANTI-HUMAN CYTOMEGALOVIRUS ACTIVITY OF PMEA (ADEFOVIR)
Authors: XIONG XF FLORES C FULLER MD MENDEL DB MULATO AS MOON K CHEN MS CHERRINGTON JM
Citation: Xf. Xiong et al., IN-VITRO CHARACTERIZATION OF THE ANTI-HUMAN CYTOMEGALOVIRUS ACTIVITY OF PMEA (ADEFOVIR), Antiviral research, 36(2), 1997, pp. 131-137
CLINICAL RESISTANCE TO INTRAVITREAL CIDOFOVIR TREATMENT IN PATIENTS WITH AIDS-RELATED CYTOMEGALOVIRUS RETINITIS
Authors: TASKINTUNA I SMITH IL RAHHAL RM POWELL HC MUELLER AJ AI E JILES RE CHERRINGTON JM SPECTOR SA FREEMAN WR
Citation: I. Taskintuna et al., CLINICAL RESISTANCE TO INTRAVITREAL CIDOFOVIR TREATMENT IN PATIENTS WITH AIDS-RELATED CYTOMEGALOVIRUS RETINITIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 3419-3419
THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: DEEKS SG COLLIER A LALEZARI J PAVIA A RODRIGUE D DREW WL TOOLE J JAFFE HS MULATO AS LAMY PD LI WX CHERRINGTON JM HELLMANN N KAHN J
Citation: Sg. Deeks et al., THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, The Journal of infectious diseases, 176(6), 1997, pp. 1517-1523
HIGH-LEVEL RESISTANCE OF CYTOMEGALOVIRUS TO GANCICLOVIR IS ASSOCIATEDWITH ALTERATIONS IN BOTH THE UL97 AND DNA-POLYMERASE GENES
Authors: SMITH IL CHERRINGTON JM JILES RE FULLER MD FREEMAN WR SPECTOR SA
Citation: Il. Smith et al., HIGH-LEVEL RESISTANCE OF CYTOMEGALOVIRUS TO GANCICLOVIR IS ASSOCIATEDWITH ALTERATIONS IN BOTH THE UL97 AND DNA-POLYMERASE GENES, The Journal of infectious diseases, 176(1), 1997, pp. 69-77
ANTI-HCMV ACTIVITY OF CIDOFOVIR IN COMBINATION WITH ANTIVIRAL COMPOUNDS AND IMMUNOSUPPRESSIVE AGENTS - IN-VITRO ANALYSES
Authors: MULATO AS CHERRINGTON JM CHEN MS
Citation: As. Mulato et al., ANTI-HCMV ACTIVITY OF CIDOFOVIR IN COMBINATION WITH ANTIVIRAL COMPOUNDS AND IMMUNOSUPPRESSIVE AGENTS - IN-VITRO ANALYSES, Antiviral chemistry & chemotherapy, 7(4), 1996, pp. 203-208
INHIBITION OF HIV-1 RNASE-H ACTIVITY BY NUCLEOTIDE DIMERS AND MONOMERS
Authors: ALLEN SJW KRAWCZYK SH MCGEE LR BISCHOFBERGER N MULATO AS CHERRINGTON JM
Citation: Sjw. Allen et al., INHIBITION OF HIV-1 RNASE-H ACTIVITY BY NUCLEOTIDE DIMERS AND MONOMERS, Antiviral chemistry & chemotherapy, 7(1), 1996, pp. 37-45
ANTIVIRAL EFFECTS OF ADEFOVIR (PMEA) AGAINST IN-VITRO REPLICATION OF WILD-TYPE AND DRUG-RESISTANT HUMAN CYTOMEGALOVIRUS (HCMV) CLINICAL ISOLATES
Authors: CHERRINGTON JM FULLER MD CHEN MS
Citation: Jm. Cherrington et al., ANTIVIRAL EFFECTS OF ADEFOVIR (PMEA) AGAINST IN-VITRO REPLICATION OF WILD-TYPE AND DRUG-RESISTANT HUMAN CYTOMEGALOVIRUS (HCMV) CLINICAL ISOLATES, AIDS, 10, 1996, pp. 10-10
EVALUATION OF ADEFOVIR (PMEA) AND PMPA IN COMBINATION WITH REVERSE-TRANSCRIPTASE AND PROTEASE INHIBITORS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN-VITRO
Authors: CHERRINGTON JM MULATO AS CHEN MS
Citation: Jm. Cherrington et al., EVALUATION OF ADEFOVIR (PMEA) AND PMPA IN COMBINATION WITH REVERSE-TRANSCRIPTASE AND PROTEASE INHIBITORS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN-VITRO, AIDS, 10, 1996, pp. 108-108
IN-VITRO SELECTION AND MOLECULAR CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH REDUCED SENSITIVITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE (PMEA)
Authors: FOLI A SOGOCIO KM ANDERSON B KAVLICK M SAVILLE MW WAINBERG MA GU ZX CHERRINGTON JM MITSUYA H YARCHOAN R
Citation: A. Foli et al., IN-VITRO SELECTION AND MOLECULAR CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH REDUCED SENSITIVITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE (PMEA), Antiviral research, 32(2), 1996, pp. 91-98
NOVEL MUTATION (K70E) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONFERS DECREASED SUSCEPTIBILITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE IN-VITRO
Authors: CHERRINGTON JM MULATO AS FULLER MD CHEN MS
Citation: Jm. Cherrington et al., NOVEL MUTATION (K70E) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONFERS DECREASED SUSCEPTIBILITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE IN-VITRO, Antimicrobial agents and chemotherapy, 40(9), 1996, pp. 2212-2216
COMPARATIVE KINETIC ANALYSES OF INTERACTION OF INHIBITORS WITH RAUSCHER MURINE LEUKEMIA-VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE TRANSCRIPTASES
Authors: CHERRINGTON JM FULLER MD MULATO AS ALLEN SJW KUNDER SC USSERY MA LESNIKOWSKI Z SCHINAZI RF SOMMADOSSI JP CHEN MS
Citation: Jm. Cherrington et al., COMPARATIVE KINETIC ANALYSES OF INTERACTION OF INHIBITORS WITH RAUSCHER MURINE LEUKEMIA-VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE TRANSCRIPTASES, Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1270-1273
9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE THERAPY OF ESTABLISHED SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN INFANT RHESUS MACAQUES
Authors: VANROMPAY KKA CHERRINGTON JM MARTHAS ML BERARDI CJ MULATO AS SPINNER A TARARA RP CANFIELD DR TELM S BISCHOFBERGER N PEDERSEN NC
Citation: Kka. Vanrompay et al., 9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE THERAPY OF ESTABLISHED SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN INFANT RHESUS MACAQUES, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2586-2591
NEW SERIES OF POTENT, ORALLY BIOAVAILABLE, NONPEPTIDIC CYCLIC SULFONES AS HIV-1 PROTEASE INHIBITORS
Authors: KIM CU MCGEE LR KRAWCZYK SH HARWOOD E HARADA Y SWAMINATHAN S BISCHOFBERGER N CHEN MS CHERRINGTON JM XIONG SF GRIFFIN L CUNDY KC LEE A YU B GULNIK S ERICKSON JW
Citation: Cu. Kim et al., NEW SERIES OF POTENT, ORALLY BIOAVAILABLE, NONPEPTIDIC CYCLIC SULFONES AS HIV-1 PROTEASE INHIBITORS, Journal of medicinal chemistry, 39(18), 1996, pp. 3431-3434
SUSCEPTIBILITY OF HUMAN CYTOMEGALOVIRUS TO CIDOFOVIR IS UNCHANGED AFTER LIMITED IN-VIVO EXPOSURE TO VARIOUS CLINICAL REGIMENS OF DRUG
Authors: CHERRINGTON JM MINER R HITCHCOCK MJM LALEZARI JP DREW WL
Citation: Jm. Cherrington et al., SUSCEPTIBILITY OF HUMAN CYTOMEGALOVIRUS TO CIDOFOVIR IS UNCHANGED AFTER LIMITED IN-VIVO EXPOSURE TO VARIOUS CLINICAL REGIMENS OF DRUG, The Journal of infectious diseases, 173(4), 1996, pp. 987-992
HIV-1 VIRAL ISOLATES WITH REDUCED SENSITIVITY TO PMEA
Authors: CHERRINGTON JM MULATO AS FULLER MD CHEN MS
Citation: Jm. Cherrington et al., HIV-1 VIRAL ISOLATES WITH REDUCED SENSITIVITY TO PMEA, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 12-12
KINETIC INTERACTION OF THE DIPHOSPHATES OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE AND OTHER ANTI-HIV ACTIVE PURINE CONGENERS WITH HIV REVERSE-TRANSCRIPTASE AND HUMAN DNA POLYMERASE-ALPHA, POLYMERASE-BETA AND POLYMERASE-GAMMA
Authors: CHERRINGTON JM ALLEN SJW BISCHOFBERGER N CHEN MS
Citation: Jm. Cherrington et al., KINETIC INTERACTION OF THE DIPHOSPHATES OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE AND OTHER ANTI-HIV ACTIVE PURINE CONGENERS WITH HIV REVERSE-TRANSCRIPTASE AND HUMAN DNA POLYMERASE-ALPHA, POLYMERASE-BETA AND POLYMERASE-GAMMA, Antiviral chemistry & chemotherapy, 6(4), 1995, pp. 217-221
HIV-1 DEVELOPS REDUCED SENSITIVITY TO 9-(2-PHOSPHONYLMETHOXYETHYL) ADENINE (PMEA) IN-VITRO THROUGH ACQUISITION OF K65R
Authors: SOGOCIO KM ANDERSON B KAVLICK M SAVILLE W WAINBERG MA CHERRINGTON JM MITSUYA H YARCHOAN R
Citation: Km. Sogocio et al., HIV-1 DEVELOPS REDUCED SENSITIVITY TO 9-(2-PHOSPHONYLMETHOXYETHYL) ADENINE (PMEA) IN-VITRO THROUGH ACQUISITION OF K65R, AIDS research and human retroviruses, 11, 1995, pp. 164-164
A RAPID ANTIVIRAL IN-SITU ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR FELINE IMMUNODEFICIENCY VIRUS
Authors: SMITH JL ALLEN SJW CHERRINGTON JM
Citation: Jl. Smith et al., A RAPID ANTIVIRAL IN-SITU ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR FELINE IMMUNODEFICIENCY VIRUS, Journal of virological methods, 54(1), 1995, pp. 29-38
Risultati: 1-25 | 26-27